Tag: Lyrica
FDA Grants First Approvals for Generic Versions of Lyrica
Generic versions approved for neuropathic pain management, fibromyalgia, partial onset seizures
Gabapentinoids Linked to Increased Risk for Significant Adverse Outcomes
Risk increased for suicidal behavior, unintentional overdose, road traffic incident, head/body injuries
Odds of Death Up With Exposure to Pregabalin, Opioids
Dose-response association with highest odds of opioid-related death with high-dose pregabalin
Pregabalin Doesn’t Cut Intensity of Sciatica-Linked Leg Pain
No significant difference in leg-pain intensity score at week eight or 52 for pregabalin, placebo
Pregabalin Benefits Not Linked to Prior Gabapentin Use
Same relief for those who had/had not received gabapentin
Pregabalin Significantly Improves Neuropathic Pain
Pregabalin-linked improvement in pain seen regardless of time since pain onset
Pregabalin in Pregnancy Linked to Increased Risk of Birth Defects
Defects include cardiac defects, structural anomalies in the central nervous system or other organs
